Subtelomeric multiplex ligation-dependent probe amplification as a supplement for rapid prenatal detection of fetal chromosomal aberrations by unknown
Chen et al. Molecular Cytogenetics 2014, 7:96
http://www.molecularcytogenetics.org/content/7/1/96RESEARCH Open AccessSubtelomeric multiplex ligation-dependent probe
amplification as a supplement for rapid prenatal
detection of fetal chromosomal aberrations
Xiangnan Chen1, Huanzheng Li2, Yijian Mao2, Xueqin Xu2, Jiaojiao Lv1, Lili Zhou2, Xiaoling Lin2
and Shaohua Tang1,2*Abstract
Background: Pregnant women with high-risk indications are highly suspected of fetal chromosomal aberrations.
To determine whether Multiplex Ligation-dependent Probe Amplification (MLPA) using subtelomeric probe mixes
(P036-E2 and P070-B2) is a reliable method for rapid detection of fetal chromosomal aberrations. The subtelomeric
MLPA probe mixes were used to evaluate 50 blood samples from healthy individuals. 168 amniocytes and 182
umbilical cord blood samples from high-risk fetuses were analyzed using the same subtelomeric MLPA probe sets.
Karyotyping was also performed in all cases of high-risk pregnancies, and single nucleotide polymorphism array
analysis was used to confirm submicroscopic and ambiguous results from MLPA/karyotyping.
Results: Subtelomeric MLPA analysis of normal samples showed normal result in all cases by use of P036-E2 probe
mix, while P070-B2 probe mix gave normal results for all but one case. In one normal control case P070-B2
produced a duplicated signal of probe for 13q34. In the high-risk group, totally 44 chromosomal abnormalities were
found by karyotyping and MLPA, including 23 aneuploidies and 21 rearrangements or mosaics. MLPA detected all
23 aneuploidies, 12 rearrangements and 1 mosaic. Importantly, MLPA revealed 4 chromosomal translocations, 2 small
supernumerary marker chromosomes (sSMCs), and 3 subtelomeric imbalances that were not well characterized or not
detectable by karyotyping. However, MLPA showed negetive results for the remaining 8 rearrangements or mosaics,
including 3 low mosaic aneuploidies, 1 inherited sSMC, and 4 paracentric inversions.
Conclusions: Results suggest that combined use of subtelomeric MLPA and karyotyping may be an alternative
method for using karyotype analyses alone in rapid detection of aneuploidies, rearrangements, and sSMCs.
Keywords: Subtelomeric MLPA, Fetal chromosomal aberrations, Aneuploidy, Rearrangements, Mosaics, sSMC, High-risk
fetuses, SNP arrayBackground
Pregnant women greater than 35 years old have in-
creased risk of aneuploid pregnancies, particularly tri-
somy 21, which produces Down’s syndrome, and trisomy
18. Positive screening of serological markers (AFP and
β-hCG), history of affected children, parental chromo-
somal rearrangement, and ultrasound identified anomal-
ies are used to test for fetal chromosomal aberrations in
high-risk pregnancies [1]. In China, amniocytes collected* Correspondence: tsh006@163.com
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unless otherwise stated.by amniocentesis at 14–23 weeks gestation or umbilical
cord blood samples obtained by cordocentesis at 24–28
weeks are used for cytogenetic analyses to detect fetal
chromosomal abnormalities [2].
Karyotyping cultured amniocytes has been the gold
standard for studying fetal chromosomal aberrations since
the 1970s [3]. However, the technique presents some limi-
tations, such as low resolution (>5 Mb), time-consumption
(10–14 weeks), and culture failure (0.2-0.6%) [4]. Over the
last two decades, probe-based tests, including quantitative
fluorescence polymerase chain reaction (QF-PCR) and
fluorescence in situ hybridization (FISH), have been
used to supplement karyotyping for rapid detection oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Karyotyping and subtelomeric MLPA results for
the 23 fetuses with aneuploidy
Karyotype Cases MLPA results*
P036-E2 P070-B2
Trisomy 21 12 Dup 21p(RBM11-1) Dup 21q(HSPA13-2)
Dup 21q(PRMT2-4) Dup 21q(S100B-2)
Trisomy 18 4 Dup 18p(USP14-7) Dup 18p(SECTM1-21)
Dup 18q(RBFA-4) Dup 18q(THOC1-9)
Trisomy 13 1 Dup 13q(PSPC1-2) Dup 13q(PSPC1-1)
Dup 13q(F7-6) Dup 13q(CDC16-8)
Monosomy X 2 Del X/Yp(SHOX-4) Del X/Yp(SHOX-5)
Del X/Yq(VAMP7-4) Del X/Yq(VAMP7-8)
47,XXX 1 Dup X/Yp(SHOX-4) Dup X/Yp(SHOX-5)
Dup X/Yq(VAMP7-4) Dup X/Yq(VAMP7-8)
47,XXY 2 Dup X/Yp(SHOX-4) Dup X/Yp(SHOX-5)
Dup X/Yq(VAMP7-4) Dup X/Yq(VAMP7-8)
One copy of Yp(ZFY-4) One copy of Yq(DDX3Y-18)
47,XYY 1 Dup X/Yp(SHOX-4) Dup X/Yp(SHOX-5)
Dup X/Yq(VAMP7-4) Dup X/Yq(VAMP7-8)
Dup Yp(ZFY-4) Dup Yq(DDX3Y-18)
*Results of probe variations were described with format as: variation type,
chromosomal arm and gene-exon (within parentheses).Dup: duplicated.
Del: deleted.
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plex Ligation-dependent Probe Amplification (MLPA) is
high-throughput, and enables analysis of more than 40
genomic locations simultaneously using only small (20 ng)
amounts of DNA [7]. MLPA is also able to distinguish se-
quences differing in only a single nucleotide and detect
small copy number differences, rapid turnaround time
which means results can be obtained within 2 work days
[8,9]. Two studies using MLPA detects big cohort of pre-
natal samples (3925 and 4000, respectively )with high risk
indications showed that MLPA is a reliable method that
can replace FISH and karyotyping used as large scale test-
ing for rapid aneuploidy diagnosis [10,11]. Other studies
shows that addition MLPA probe mixes targeted subtelo-
meric regions and microdeletion syndromes can increase
detection of pathogenic rearrangements which are valu-
able in routine prenatal diagnostics [12-14].
Subtelomeric MLPA probe mixes contain probes for
subtelomeric or pericentromeric regions, which were de-
signed to detect subtelomeric rearrangements. Postnatally,
the probe mixes are already used in clinical genetics for de-
tection of copy number variations (CNVs) in subtelomeric
regions, which are gene-rich and prone to rearrangement
in patients with intellectual disability [15-17]. For prenatal
diagnostics, detection of DNA from prenatal samples also
showed the probe sets have potential to detect common
aneuploidies and increase detection of chromosomal rear-
rangements [2,13]. However, the presence of CNVs in the
human genome has been widely demonstrated, and differ-
ent ethnic populations may present different polymor-
phisms [18,19]. To determine whether subtelomeric MLPA
is suitable for the Chinese population, P036-E2 and P070-
B2 probe sets were evaluated. In this study,we used subte-
lomeric MLPA as a supplementary method to karyotyping
for the detection of fetal chromosomal aberrations in
second-trimester high-risk pregnancies.
Results
Subtelomeric MLPA probe set evaluation
In total 50 DNA samples extracted from peripheral blood
of healthy individuals were analyzed. P036-E2 MLPA sub-
telomeric probe mix showed normal results for all ana-
lyzed samples. In one case P070-B2 MLPA subtelomeric
probe mix showed duplication of the probe located in
13q34 (CDC16-8). The relative ratio of each probe signal
was 1 ± 0.01 SD <0.1 (Additional file 1).High-risk pregnancy samples
In the high-risk pregnancy group, 44 (12.6%) of 350 cases
were found to have chromosomal aberrations using the
combination of MLPA probe sets and karyotyping. De-
tected abnormalities included 23 aneuploidies and 21 rear-
rangements or mosaics (Table 1 and Table 2).Karyotyping results
Karyotyping alone detected 41 chromosomal abnormal-
ities, including 23 aneuploidies, 8 terminal imbalanced
rearranggements, 4 mosaics, 4 paracentric inversions and
3 sSMCs(one was mosaic). Different chromosomal band
was involved in the 8 terminal imbalanced rearrangge-
ments, including 2q, 4p, 5p, 6q, 10q, 14q, 18p and 21q.
Level of the 4 mosaics are 15%, 25%, 26% and 42%, re-
spectively. In the 4 paracentric inversions, 3 involved
chromosome 9 and the remaining one involved chromo-
some 7 which was inherited from a healthy mother.
Subtelomeric MLPA anlaysis
MLPA detected all the 23 aneuploidies and each showed
at least two probe changes for one MLPA probe set
(Table 1). And 12 rearrangements and 1 mosaic were also
detected, 3 of which were missed by karyotype analyses
and 10 of which were both detected by MLPA and karyo-
typing (Table 2). MLPA revealed unbalanced chromo-
somal translocations in 4 of the rearrangements that were
not microscopically detectable: 2qter deletion and 3pter
duplication (46,XY,add(2)(q37)); 14qter deletion and 4qter
duplication (46,XX,add(14)(q32)); 21qter deletion and
17qter duplication (46,XY,add(21)(q22)) (Figure 1); 6qter
deletion and 18pter duplication (46,XX,add(6)(q27)). Two
of the sSMCs, one of which was mosaic(42%), were also
identified by MLPA. However, MLPA showed negative
Table 2 Details of the 21 rearrangements or mosaics detected by full karyotyping and subtelomeric MLPA
Karyotype on
cultured cells
Sample type** Indication*** MLPA results
P036-E2 P070-B2
46,XX Amnio UA Del 7q(VIPR2-3) Del 7q(VIPR2-2)
46,XY Amnio UA Dup 16p(POLR3K-1) Dup 16p(DECR2-9)
46,XX CB UA Del 11q(NCAPD3-2) Del 11q(IGSF9B-20)
Dup 9q(EHMT1-24) Dup 9q(EHMT1-10)
45,XX,psu dic(4;22)(p11;p11.2) CB UA Del 4p(PIGG-7) Del 4p(PIGG-8)
46,XX,del (5)(p13) CB UA Del 5p(PDCD6-6) Del 5p(CCDC127-3)
46,XX,del(10)(q26) Amnio PHGI Del 10q(PAOX-3) Del 10q(ECHS1-8)
46,XX,del(18)(p10) Amnio IASR Del 18p(USP14-7) Del 18p(THOC1-21)
46,XY,add(2) (q37) Amnio UA Del 2q(CAPN10-3) Del 2q(ATG4B-7)
Dup 3p(CHL1-5) Dup 3p(CHL1-3)
46,XX,add(14) (q32) Amnio PTC Dup 4q(TRIML2-2) Dup 4q(FRG1-1)
Del 14q(MTA1-8) Del 14q(MTA1-7)
46,XY,add(21) (q22) CB IASR Dup 17q(TBCD-18) Dup 17q(SECTM1-4)
Del 21q(PRMT2-4) Del 21q(S100B-2)
46,XX,add(6)(q27) Amnio PHGI Del 6q(PSMB1-5) Del 6q(TBP-2)
Dup 18p(USP14-7) Dup 18p(THOC1-21)
mos 47,XY,+mar[9]/46,XY[12] Amnio IASR’ Dup 21q(RBM11-1) Dup 21q(HSPA13-2)
46,X,+mar Amnio IASR Dup X/Yp(SHOX-4) Dup X/Yp(SHOX-5)
Del X/Yq(VAMP7-4) Del X/Yq(VAMP7-8)
Dup Yp(ZFY-4) Dup Yq(DDX3Y-18)
46,XN,inv(9)* Amnio IASR Normal Normal
46,XX,inv(7)(q22q31)(mat) Amnio PHGI Normal Normal
47,XX,+mar(pat) Amnio IASR Normal Normal
mos 47,XX,+21[5]/46,XX[15] Amnio IASR Normal Normal
mos 47,XX,+7[3]/46,XX,[17] Amnio IASR Normal Normal
mos 45,X[6]/46,XY[17] Amnio HRA Normal Normal
*3 femal and 1 male fetuses with 46,XN,inv(9).
**Amnio: amniocyte; CB: cord blood.
***UA: Ultrasound abnormality; PTC: Parental translocation carrier; HRA: High-risk age; IASR: Increased aneuploidy screening risk; PHGI: Past history of genetic indications.
mos: mosaic; mar: marker.
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26%), one inherited sSMC and all 4 paracentric inversions,
which were detected by karyotyping.SNP array analyses
SNP array analyses were performed for the 3 rearrange-
ments that were revealed by MLPA but not detected by
karyotyping. Results confirmed the deletion of 7qter with a
minimum size of 0.1 Mb, Chr7:g. 158064729–159119486;
duplication of 16pter with a minimum size of 0.3 Mb,
Chr16:g. 152220–480875; and partial monosomy of 11q
and partial trisomy of 9q. SNP array analyses also revealed
that the 11q deletion spanned approximately 10.2 Mb, and
the 9q duplication spanned 12.9 Mb.Discussion and conclusions
To improve detection rates of chromosomal aberrations
for high-risk pregnancies, new rapid and reliable prenatal
diagnostic tests are needed. Many different diagnostic ap-
proaches have been reported, including QF-PCR, targeted
FISH, and genome wide technologies such as SNP arrays
and comparative genomic hybridization [20-22]. This
study focused on MLPA as a supplement for current tests.
This technology is high-throughput, with up to 96 samples
analyzed in each run [23]. It is also economical, easy to
perform, reproducible, and sensitive.
Totally 400 DNA samples (50 blood samples from
healthy individuals and 350 prenatal samples) were
assayed. The 50 blood samples were assayed in a single ex-
periment, and the results, including data analyses, were
Figure 1 Identification of chromosomal rearrangements with karyotype analyses and MLPA. (A) Karyotype analysis showed a derived
chromosome 21 (black arrow). Band analyses revealed the derived chromosome was longer than chromosome 21 and the two copies of
chromosome 17 were normal. (B) MLPA results with probe P036-E2 (left) and P070-B2 (right). Probes targeting 17q25.3 (blue dot) were increased
and the signals for 21q22.3 (red dot) were decreased, indicating unbalanced translocation with deletion of 21qter and duplication of 17qter.
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cation of the probe located in 13q34 (CDC16-8) for
P070-B2 MLPA subtelomeric probe mix. Based on the
database of genomic variants (DGV:dgv.tcag.ca/gb2/
gbrowse/dgv2_hg19/), this duplicated region may be a
benign copy number variation in normal individual.
However, variability in probe signals can occur due to
variations in sample purity and experimental conditions.
There is no further validation has been made, this may
be a false positive results detected by MLPA.
Results of subtelomeric MLPA analysis of 350 DNA
samples from high-risk pregnancies were analyzed by sub-
telomeric MLPA, revealing 36 abnormal results, including
23 aneuploidies and 13 rearrangements or mosaics. These
findings demonstrate that subtelomeric MLPA can identify
all major aneuploidies and many chromosomal rearrange-
ments that are not well characterized by karyotyping or
not detectible by karyotyping.
MLPA is especially useful for characterizing unbal-
anced rearrangements as a complement to conventional
cytogenetics [12]. Indeed, MLPA detected unbalanced
subtelomeric translocations in 4 cases of deletion and
duplication, but karyotyping only showed some addition
in one of the chromosomes. Characterization of this type
of rearrangement with short turnaround time is crucial
for prenatal diagnoses.
Detection of mosaics by MLPA is dependent on the level
of the mosaic. In this study, four mosaics detected by
karyotyping had levels of 42%, 25%, 15%, and 26%, andonly the 42% mosaic sSMC was detected by subtelomeric
MLPA. It is consistent with previous study that MLPA can
detect duplicated mosaics to a level as low as 40% [24].
sSMC detection was also tested. Three sSMCs were de-
tected by karyotyping, and 2 of them were also detected by
subtelomeric MLPA. Parental karyotyping revealed that
the 2 positive sSMCs were de novo. Previous studies
showed that both centromeric and subtelomeric MLPA
probe sets can rapidly distinguish unique-sequence positive
and negative sSMCs [25]. However, Detection of aberration
by MLPA technique is limited by probe location.
Cryptic, unbalanced subtelomeric rearrangements have
been identified as an important contributor (0.5-4.1%) to
the etiology of fetal malformations [8,26,27]. In this study, 3
(0.8%) normal karyotypes were found to have chromosomal
imbalances by MLPA, including a 7qter deletion, a 16pter
duplication, and an unbalanced translocation with 11qter
deletion and 9qter duplication. Further characterization of
the 7qter deletion and 16pter duplication using SNP arrays
revealed that these two imbalances were smaller than
3 Mb, what is usually under detection resolution of conven-
tionally by karyotyping. Partial monosomy 11q and partial
trisomy 9q should be detectable using high-resolution
karyotype analysis, because SNP arrays revealed that they
spanned approximately 10.2 Mb and 12.9 Mb, respectively.
Using this information, it was deduced that the derivative
chromosome was 2.7 Mb longer than chromosome 11. The
replacement region, 9q33.3q34.3, stained similar to region
11q24.2q25 in cytogenetic analyses at a resolution of 350–
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to a misdiagnosis by karyotype analysis.
Using subtelomeric MLPA probe mix in prenatal diag-
noses allows a rapid fetal chromosomal analysis and pos-
sible it could increase detection rates for chromosomal
rearrangements. However, the precise breakpoints of the
rearrangements can’t be established by either karyotyping
or MLPA. SNP array analysis may overcome this obstacle.
SNP array testing is faster and allows detection of
much smaller aberrations (approximately 0.15 Mb) com-
pared to karyotyping (approximately >5 Mb) [28,29].
However, SNP technology is costly and technically com-
plex. Therefore, it is not considered suitable for routine
diagnostic use in developing countries. In contrast, sub-
telomeric MLPA, as a supplementary tool for karyotype
analyses to detect fetal chromosomal aberrations, is feas-
ible in diverse settings. In addition, MLPA probemix
P290 Prenatal Microdeletions has been developed to
simultaneously screen prenatal samples for trisomies 13,
18, 21 and for several microdeletion syndromes. Combined
using this probemix with subtelomeric MLPA probemixes
may be more reliable for aneuploidy detection and increase
diagnostic yield for chromomal rearrangements. However,
for confirming chromosomal rearrangements detected by
karyotyping/MLPA, or analyzing suspected aberrations
not revealed by MLPA/karyotyping, genome-wide array
methods may be a good choice.
Methods
Materials
Fifty peripheral blood samples were collected from
healthy individuals (39 males, 11 females, average age is
27, range: 23 to 35) at the Health Check Centre of Wen-
zhou Central Hospital. In total 350 pregnant women
underwent fetal karyotype analyses by amniocentesis or
cordocentesis. The average age of pregnant women was
28, and the range was 20 to 35. 168 samples of amniotic
fluid were obtained at an average gestation of 20 weeks
(range: 17 to 23). 182 cord blood samples were obtained
at 24 to 30 weeks gestation (average: 26 weeks). Patients
were classified into five groups based on prenatal indica-
tions (Table 3). All patients were informed about theTable 3 Classification of the high-risk pregnancy samples
according to prenatal indications
Classifications Amniocytes Umbilical cord blood
Ultrasound abnormality 54 90
Increased aneuploidy screening risk 62 31
High age risk 32 28
Past history of genetic indications 17 32
Parental translocation carrier 3 1
Total 168 182study, and written consents for participation were ob-
tained. This study is approved by the Dingli Clinical
School Ethics Committee of Wenzhou Medical University
(NO.201410).Karyotype analyses
All prenatal samples were cultured following standard
protocols [3]. Amniocytes were cultured with BIOAMF-2
medium (Biological Industry, Kibbutz Beit Haemek,
Israel), and cord blood cells were cultivated with periph-
eral blood lymphocyte medium (Xiangya gene technology,
Hunan, China). At least 20 G-banded metaphases from
each sample were analyzed using G-banding Wright-
staining method. Karyotypes were analyzed by two senior
laboratory technicians.DNA for MLPA
Five ml uncultured amniotic fluid or 200 μl blood sam-
ples were used to isolate DNA with the QIAamp DNA
Mini kit (Qiagen, Germany). Purified DNA was eluted
with 50–200 μl of AE buffer. Sample concentration and
purity were detected using a NanoDrop 2000UV-vis
spectrophotometer (Thermo Scientific, USA).MLPA
Subtelomeric MLPA probe sets, P036-E2 and P070-B2,
were supplied by MRC-Holland (http://www.mlpa.com).
Each probe set contains one MLPA probe for subtelo-
meric or pericentromeric regions, which are primarily de-
signed to detect deletions/duplications. We used at least 2
reference samples in each MLPA run. When using more
than 8 samples, added 1 additional reference sample for
each 3 samples. Reference samples are DNA from nomal
controls. DNA was diluted to 20–30 ng/μl and 5 μl DNA
was used in each MLPA reaction. An ABI-2720 thermocy-
cler (USA) was used for MLPA, following the manufac-
turer’s instructions. ABI 3130 was used for fragment
separation and the parameters were set as follows: Injec-
tion voltage: 1.6 kV; injection time: 15 seconds; run volt-
age: 15 kV; polymer: POP7; run voltage: 10 kV, and run
time: 2000 seconds. Data was analyzed using Coffalyser.
NET software developed by the manufacturer. All analyt-
ical parameters were set to default. The algorithm of
Coffalyser.NET primarily runs two steps: firstly, data for
each test probe of each sample will be compared to each
available reference sample, producing as many dosage
quotients as there are reference samples;secondly, final ra-
tio will then estimated by calculating the average over
these dosage quotients. In this study, arbitrary ratio border
(low: 0.70; high: 1.30) was used for the final ratio to deter-
mine whether an abnormal result was detected.
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We used the HumanCytoSNP-12 v1.0 (Illumina, USA)
SNP array platform, which contains 298,563 tagSNP
markers with an average resolution of 31 Kb. Two hun-
dred ng DNA was used as input for each array. DNA amp-
lification, tagging, and hybridization were performed
according to manufacturer’s protocols. Array slides were
scanned on an iScan reader. Data analysis was performed
using GenomeStudio (version 2010.1). The breakpoint po-
sitions of each aberrant region were converted to Genome
Reference Consortium Human Build 37 patch release 13
(GRCh37.p13).
Additional file
Additional file 1: Data of each probe collected from healthy
individuals by performing subtelomeric MLPA.
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